|
KMID : 0614620210780020105
|
|
Korean Journal of Gastroenterology
2021 Volume.78 No. 2 p.105 ~ p.116
|
|
|
KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement
|
|
Park Yong-Eun
Lee Yoo-Jin
Chang Ji-Young
Song Hyun-Joo
Kim Duck-Hwan
Yang Young-Joo
Kim Byung-Chang
Lee Jae-Gon
Yang Hee-Chan
Choi Mi-Young
Kim Seong-Eun
Myung Seung-Jae
|
|
|
Abstract
|
|
|
|
The coronavirus disease 2019 (COVID-19) pandemic has reduced the ability to prevent or control chronic disease due to the concerns about safety in accessing health care. Inflammatory bowel disease (IBD) is a chronic condition requiring long- term sustained treatment, which is difficult in the current panedemic situation. The Korean Association for the Study of Intestinal Diseases (KASID) has developed an expert consensus statement on the clinical practice management of adult inflammatory bowel disease during the COVID-19 pandemic. This expert consensus statement is based on guidelines and clinical reports from several countries around the world. It provides recommendations to deal with the risk of COVID-19 and medication use in IBD patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and emphasizes the importance of right treatment approach to avoid worsening of the disease condition in IBD patients.
|
|
|
KEYWORD
|
|
|
SARS-CoV-2, COVID-19, Inflammatory bowel diseases, Disease management
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|